Tuberculosis Global Clinical Trials Review, H1, 2012
Tuberculosis Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Tuberculosis Global Clinical Trials Review, H1, 2012" provides data on the Tuberculosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tuberculosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tuberculosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Summary
GlobalData's clinical trial report, “Tuberculosis Global Clinical Trials Review, H1, 2012" provides data on the Tuberculosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tuberculosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tuberculosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Contents
IntroductionTuberculosis
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Tuberculosis
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Tuberculosis Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Aeras Global Tb Vaccine Foundation
Clinical Trial Overview of Aeras Global Tb Vaccine Foundation
Global Alliance for TB Drug Development
Clinical Trial Overview of Global Alliance for TB Drug Development
Otsuka Pharmaceutical Co., Ltd.
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd.
Vakzine Projekt Management GmbH
Clinical Trial Overview of Vakzine Projekt Management GmbH
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Sanofi
Clinical Trial Overview of Sanofi
EPICENTRE Biotechnologies
Clinical Trial Overview of EPICENTRE Biotechnologies
Apothecaries Private Limited
Clinical Trial Overview of Apothecaries Private Limited
Tibotec BVBA
Clinical Trial Overview of Tibotec BVBA
G.S.V.M. Medical College
Clinical Trial Overview of G.S.V.M. Medical College
RIEMSER Arzneimittel AG
Clinical Trial Overview of RIEMSER Arzneimittel AG
Archivel Farma S.L.
Clinical Trial Overview of Archivel Farma S.L.
Lupin Limited
Clinical Trial Overview of Lupin Limited
Acoustic MedSystems, Inc.
Clinical Trial Overview of Acoustic MedSystems, Inc.
Merz GmbH & Co. KGaA
Clinical Trial Overview of Merz GmbH & Co. KGaA
Novartis AG
Clinical Trial Overview of Novartis AG
Sequella, Inc.
Clinical Trial Overview of Sequella, Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
The National Institute of Allergy and Infectious Diseases
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
University of Oxford
Clinical Trial Overview of University of Oxford
Centers for Disease Control and Prevention
Clinical Trial Overview of Centers for Disease Control and Prevention
University of Cape Town
Clinical Trial Overview of University of Cape Town
Statens Serum Institut
Clinical Trial Overview of Statens Serum Institut
Johns Hopkins University
Clinical Trial Overview of Johns Hopkins University
French National Agency for Research on AIDS and Viral Hepatitis
Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis
National Taiwan University Hospital
Clinical Trial Overview of National Taiwan University Hospital
Seoul National University Hospital
Clinical Trial Overview of Seoul National University Hospital
Tuberculosis Research Centre
Clinical Trial Overview of Tuberculosis Research Centre
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
All India Institute of Medical Sciences
Clinical Trial Overview of All India Institute of Medical Sciences
Yonsei University
Clinical Trial Overview of Yonsei University
Ministry of Science & Technology
Clinical Trial Overview of Ministry of Science & Technology
Taipei Medical University WanFang Hospital
Clinical Trial Overview of Taipei Medical University WanFang Hospital
Hopitaux Universitaires de Geneve
Clinical Trial Overview of Hopitaux Universitaires de Geneve
Health Protection Agency
Clinical Trial Overview of Health Protection Agency
Radboud University
Clinical Trial Overview of Radboud University
Texas Tech University Health Sciences Center
Clinical Trial Overview of Texas Tech University Health Sciences Center
Harvard School of Public Health
Clinical Trial Overview of Harvard School of Public Health
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
LIST OF TABLES
Tuberculosis Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Tuberculosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Tuberculosis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Tuberculosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
Tuberculosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Tuberculosis Therapeutics Clinical Trials, North America, Top Countries, 2012*
Tuberculosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012*
Tuberculosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012*
Tuberculosis Therapeutics Clinical Trials, BRIC Countries, 2012*
Tuberculosis Therapeutics Clinical Trials, G7 Countries, 2012*
Tuberculosis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Tuberculosis Therapeutics Clinical Trials, E7 Countries, 2012*
Tuberculosis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Tuberculosis Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Tuberculosis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Tuberculosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Tuberculosis Therapeutics Market, Global, Suspended Clinical Trials, 2012*
Tuberculosis Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
Tuberculosis Therapeutics Market, Global, Terminated Clinical Trials, 2012*
Tuberculosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Tuberculosis Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Tuberculosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Tuberculosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Aeras Global Tb Vaccine Foundation, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Global Alliance for TB Drug Development, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Pharmaceutical Co., Ltd., 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Vakzine Projekt Management GmbH, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by EPICENTRE Biotechnologies, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Apothecaries Private Limited, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tibotec BVBA, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by G.S.V.M. Medical College, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by RIEMSER Arzneimittel AG, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Archivel Farma S.L., 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Lupin Limited, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Acoustic MedSystems, Inc., 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz GmbH & Co. KGaA, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sequella, Inc., 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cape Town, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Statens Serum Institut, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by French National Agency for Research on AIDS and Viral Hepatitis, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tuberculosis Research Centre, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Science & Technology, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Taipei Medical University WanFang Hospital, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopitaux Universitaires de Geneve, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Health Protection Agency, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Texas Tech University Health Sciences Center, 2012*
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Harvard School of Public Health, 2012*
LIST OF FIGURES
Tuberculosis Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Tuberculosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Tuberculosis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Tuberculosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
Tuberculosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
Tuberculosis Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Tuberculosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012*
Tuberculosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012*
Tuberculosis Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Tuberculosis Therapeutics Clinical Trials, G7 Countries (%), 2012*
Tuberculosis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Tuberculosis Therapeutics Clinical Trials, E7 Countries (%), 2012*
Tuberculosis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Tuberculosis Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Tuberculosis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Tuberculosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Tuberculosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Tuberculosis Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Tuberculosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Tuberculosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology Skip to top